Target intelligence / Profile preview

Host gastrointestinal mucus and epithelial extracellular matrix (GI mucus and ECM)

Target
GI mucus and ECM
Molecular classification
Extracellular matrix, Glycoprotein, Proteoglycan, Structural protein, Other
01

Overview

The host gastrointestinal mucus and epithelial extracellular matrix (ECM) represent a complex, multi-component barrier system essential for intestinal health and homeostasis. The mucus layer, primarily composed of the gel-forming glycoprotein Mucin-2 (MUC2), acts as a physical and chemical shield against pathogens, toxins, and digestive enzymes while housing the commensal microbiota (Johansson et al., 2011, Nature Reviews Gastroenterology & Hepatology). Directly beneath the epithelial cells, the ECM provides a structural scaffold consisting of proteins like collagen, laminin, and fibronectin, which are critical for cell signaling, adhesion, and tissue repair (Bonnans et al., 2014, Nature Reviews Molecular Cell Biology). In pathological states such as inflammatory bowel disease (IBD) or gastric ulcers, this barrier is often degraded or dysfunctional, leading to chronic inflammation and tissue damage. Therapeutic interventions include mucolytics like N-acetylcysteine to manage hypersecretion, and mucosal protectants like sucralfate that bind to the ECM in ulcerated areas to promote healing (StatPearls, 2023). Additionally, targeting ECM-cell interactions via integrin inhibitors is a key strategy in treating intestinal inflammation and preventing cancer metastasis.

Other names
Gastrointestinal mucosal barrierIntestinal extracellular matrixMucus-ECM complexIntestinal barrier
02

Mechanism of action

Modification of mucus rheology, physical shielding of the epithelium, and modulation of cell-extracellular matrix adhesion.

03

Biological functions

Physical barrierCell adhesionLubricationImmune responseStructural supportOther
04

Disease associations

InflammationCancerInfectionOther
05

Safety considerations

Increased intestinal permeability (leaky gut)Malabsorption syndromesDisruption of the gut microbiome
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Mucin-2 (MUC2)Fecal calprotectinZonulinCollagen type III pro-peptide (PRO-C3)

Beyond the preview

Go deeper on Host gastrointestinal mucus and epithelial extracellular matrix (GI mucus and ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host gastrointestinal mucus and epithelial extracellular matrix (GI mucus and ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call